Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07132307 · ClinicalTrials.gov registry record · NA

Reducing Obstructive Sleep Apnea After Hypoglossal Nerve Stimulation Through Mandibular Advancement

A NA study of Obstructive Sleep Apnea, sponsored by Washington University School of Medicine.

Recruiting
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT07132307 is a NA study of Obstructive Sleep Apnea that is actively recruiting participants, run by Washington University School of Medicine. The registered enrollment target is 30 participants, below the 221-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07132307, a NA study of Obstructive Sleep Apnea, is actively recruiting participants, sponsored by Washington University School of Medicine.

RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to evaluate the effectiveness, feasibility, and safety of mandibular advancement devices (MAD) for treating severe obstructive sleep apnea (OSA) in patients who are CPAP intolerant and have failed hypoglossal nerve stimulation (HGNS).

Conditions Studied

Interventions

  • DEVICE Mandibular advancement device (MAD)

Study Locations (1)

Missouri

  • Washington University School of Medicine - St Louis

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2025-07-29
Est. Completion 2027-02-01
Phase NA

What the Registry Record Tells You About NCT07132307

The ClinicalTrials.gov registry entry for NCT07132307 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 221-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (86% lower). The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Obstructive Sleep Apnea appearing as the primary indexed condition, and to 1 intervention - of which Mandibular advancement device (MAD) is the first listed.

NCT07132307 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.

Frequently Asked Questions

What is clinical trial NCT07132307 about?

NCT07132307 is a clinical study titled "Reducing Obstructive Sleep Apnea After Hypoglossal Nerve Stimulation Through Mandibular Advancement". The purpose of this study is to evaluate the effectiveness, feasibility, and safety of mandibular advancement devices (MAD) for treating severe obstructive sleep apnea (OSA) in patients who are CPAP intolerant and have failed hypoglossal nerve stimulation (HGNS).

What is the current status of trial NCT07132307?

This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2025-07-29. Estimated completion is 2027-02-01.

What conditions does trial NCT07132307 study?

This clinical trial studies the following conditions: Obstructive Sleep Apnea.

What interventions are being tested in trial NCT07132307?

The interventions under investigation include: Mandibular advancement device (MAD) (DEVICE).

Who is sponsoring clinical trial NCT07132307?

This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07132307 being conducted?

This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obstructive Sleep Apnea

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.